Lv4
420 积分 2022-08-19 加入
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation
21小时前
待确认
Oral Muvalaplin for Lowering of Lipoprotein(a)
21小时前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
21天前
已完结
Rapid One‐Pot Access to Unique 3,4‐Dihydrothiopyrano[3,4‐b]indol‐1(9H)‐imines via Bi(OTf)3‐Catalysed Tandem Friedel–Crafts Alkylation/Thia‐Michael Addition
1个月前
已完结
Oxidation of Primary Alcohols and Aldehydes to Carboxylic Acids with 1-Hydroxycyclohexyl Phenyl Ketone
1个月前
已完结
The New Frontier: Merging Molecular Glue Degrader and Antibody–Drug Conjugate Modalities To Overcome Strategic Challenges
1个月前
已完结
Natural molecular glues spur next-gen small molecules for ‘undruggable’ targets
1个月前
已完结
The Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of Orally Dosed QY201, a Novel JAK1/TYK2 Inhibitor, in Chinese Healthy Subjects
2个月前
已完结
Au-Ag-PDA@MSCM的光热效应介导皮脂腺细胞铁死亡抑制皮脂分泌的作用及机制研究
2个月前
已完结
Iron Catalysis for Room-Temperature Aerobic Oxidation of Alcohols to Carboxylic Acids
3个月前
已完结
皖公网安备34019202002308
